Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Photons | 3 | 2015 | 588 | 1.100 |
Why?
|
| Biosensing Techniques | 3 | 2015 | 668 | 0.710 |
Why?
|
| Crystallization | 3 | 2014 | 524 | 0.650 |
Why?
|
| src-Family Kinases | 3 | 2015 | 551 | 0.610 |
Why?
|
| Nanoparticles | 2 | 2015 | 1905 | 0.440 |
Why?
|
| Microscopy | 2 | 2014 | 903 | 0.400 |
Why?
|
| Protein Interaction Mapping | 1 | 2014 | 627 | 0.360 |
Why?
|
| Metal Nanoparticles | 1 | 2014 | 405 | 0.340 |
Why?
|
| Hepatitis C | 3 | 2023 | 1591 | 0.310 |
Why?
|
| Biocompatible Materials | 1 | 2015 | 1736 | 0.290 |
Why?
|
| Wound Healing | 1 | 2015 | 2785 | 0.240 |
Why?
|
| Fluorescence Resonance Energy Transfer | 3 | 2015 | 401 | 0.220 |
Why?
|
| Evoked Potentials | 1 | 2009 | 1056 | 0.220 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2021 | 3327 | 0.210 |
Why?
|
| Endothelial Cells | 1 | 2015 | 3479 | 0.210 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 2 | 2012 | 182 | 0.200 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2009 | 1534 | 0.190 |
Why?
|
| Hepacivirus | 3 | 2023 | 1379 | 0.190 |
Why?
|
| Models, Neurological | 1 | 2009 | 1774 | 0.180 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2023 | 35421 | 0.170 |
Why?
|
| Arteries | 1 | 2023 | 1119 | 0.160 |
Why?
|
| Epidemics | 1 | 2023 | 523 | 0.150 |
Why?
|
| Spectrophotometry, Ultraviolet | 2 | 2014 | 220 | 0.140 |
Why?
|
| Cell Surface Extensions | 1 | 2015 | 67 | 0.130 |
Why?
|
| Algorithms | 2 | 2022 | 13881 | 0.130 |
Why?
|
| Brain | 4 | 2023 | 26385 | 0.120 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2013 | 120 | 0.110 |
Why?
|
| Optical Phenomena | 1 | 2013 | 107 | 0.110 |
Why?
|
| Surface Plasmon Resonance | 1 | 2014 | 274 | 0.110 |
Why?
|
| Mesenchymal Stem Cells | 2 | 2013 | 1632 | 0.100 |
Why?
|
| Protein Binding | 2 | 2015 | 9386 | 0.100 |
Why?
|
| Cell Polarity | 1 | 2015 | 645 | 0.100 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2021 | 1363 | 0.100 |
Why?
|
| Electromagnetic Fields | 1 | 2014 | 298 | 0.100 |
Why?
|
| Chemotaxis | 1 | 2013 | 607 | 0.090 |
Why?
|
| Sarcoma | 1 | 2021 | 1897 | 0.090 |
Why?
|
| Gold | 1 | 2014 | 484 | 0.090 |
Why?
|
| Neovascularization, Physiologic | 1 | 2015 | 1351 | 0.080 |
Why?
|
| Antigens | 1 | 2014 | 1466 | 0.080 |
Why?
|
| Phantoms, Imaging | 2 | 2021 | 2480 | 0.080 |
Why?
|
| Rabbits | 1 | 2014 | 4894 | 0.070 |
Why?
|
| Equipment Design | 1 | 2015 | 3582 | 0.070 |
Why?
|
| Osteoblasts | 1 | 2012 | 1166 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2023 | 8949 | 0.070 |
Why?
|
| Computer Simulation | 2 | 2022 | 6196 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2013 | 11483 | 0.070 |
Why?
|
| Antibodies | 1 | 2014 | 2460 | 0.070 |
Why?
|
| Moldova | 1 | 2023 | 15 | 0.060 |
Why?
|
| Cell Movement | 1 | 2015 | 5217 | 0.060 |
Why?
|
| Georgia (Republic) | 1 | 2021 | 41 | 0.050 |
Why?
|
| Enzyme Activation | 3 | 2013 | 3701 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2021 | 19905 | 0.050 |
Why?
|
| Spin Labels | 1 | 2023 | 332 | 0.050 |
Why?
|
| Perfusion Imaging | 1 | 2023 | 195 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2011 | 3748 | 0.050 |
Why?
|
| Microbiological Techniques | 1 | 2021 | 102 | 0.050 |
Why?
|
| Stem Cells | 1 | 2013 | 3567 | 0.050 |
Why?
|
| Artifacts | 1 | 2009 | 1904 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 2 | 2022 | 5391 | 0.040 |
Why?
|
| Perfusion | 1 | 2023 | 1360 | 0.040 |
Why?
|
| Markov Chains | 1 | 2021 | 969 | 0.040 |
Why?
|
| Image Enhancement | 1 | 2009 | 2921 | 0.040 |
Why?
|
| Oxygen | 1 | 2009 | 4189 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2009 | 3589 | 0.040 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2022 | 783 | 0.030 |
Why?
|
| Cell Adhesion | 2 | 2013 | 3144 | 0.030 |
Why?
|
| Observer Variation | 1 | 2021 | 2593 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2021 | 1683 | 0.030 |
Why?
|
| Humans | 11 | 2023 | 744343 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 14722 | 0.030 |
Why?
|
| Cells, Cultured | 3 | 2013 | 19229 | 0.030 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2021 | 1624 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2022 | 3760 | 0.030 |
Why?
|
| RNA | 1 | 2022 | 2749 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2013 | 479 | 0.020 |
Why?
|
| Public Health | 1 | 2023 | 2603 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2023 | 4042 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2021 | 2987 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2012 | 865 | 0.020 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2011 | 625 | 0.020 |
Why?
|
| Heart | 1 | 2021 | 4467 | 0.020 |
Why?
|
| ras Proteins | 1 | 2013 | 1060 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 1970 | 0.020 |
Why?
|
| Animals | 3 | 2014 | 168757 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2013 | 1692 | 0.020 |
Why?
|
| Mass Screening | 1 | 2021 | 5255 | 0.020 |
Why?
|
| Osteogenesis | 1 | 2012 | 1299 | 0.020 |
Why?
|
| Kinetics | 1 | 2012 | 6473 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2011 | 3846 | 0.010 |
Why?
|
| Tissue Engineering | 1 | 2013 | 1880 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2013 | 4554 | 0.010 |
Why?
|
| Adult | 2 | 2022 | 214055 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2011 | 14557 | 0.010 |
Why?
|
| Mice | 2 | 2013 | 81183 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2013 | 23403 | 0.010 |
Why?
|
| Male | 1 | 2021 | 350118 | 0.000 |
Why?
|
| Female | 1 | 2021 | 380194 | 0.000 |
Why?
|
Concepts
(97)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(15)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_